Nuzenio

Neurocrine Biosciences Begins

Neurocrine Biosciences Begins news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Neurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 13:34:39 GMT Neurocrine Biosciences Begins Phase 1 Study of GLP-1/GIP/Glucagon Triple Agonist NBIP-'1968 for Obesity - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 17:19:41 GMT Neurocrine’s Investigational Obesity Drug Targets Three Receptors - Stock TitanStock Titan · Fri, 07 Aug 2026 12:30:00 GMT Voyager Therapeutics reports Q2 2026 net loss $24.5M, cash $148.8M; runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMT Neurocrine Biosciences Expands Portfolio and Raises 2026 Growth Guidance - sekbernews.idsekbernews.id · Sat, 01 Aug 2026 08:17:31 GMT [10-Q] NEUROCRINE BIOSCIENCES INC Quarterly Earnings Report - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMT Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 13:34:39 GMTNeurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity - Clinical Trials Arena

Fri, 07 Aug 2026 17:19:41 GMTNeurocrine Biosciences Begins Phase 1 Study of GLP-1/GIP/Glucagon Triple Agonist NBIP-'1968 for Obesity - BioPharm International

Fri, 07 Aug 2026 12:30:00 GMTNeurocrine’s Investigational Obesity Drug Targets Three Receptors - Stock Titan

Thu, 06 Aug 2026 20:13:22 GMTVoyager Therapeutics reports Q2 2026 net loss $24.5M, cash $148.8M; runway into 2028 - TradingView

Sat, 01 Aug 2026 08:17:31 GMTNeurocrine Biosciences Expands Portfolio and Raises 2026 Growth Guidance - sekbernews.id

Fri, 31 Jul 2026 07:00:00 GMT[10-Q] NEUROCRINE BIOSCIENCES INC Quarterly Earnings Report - Stock Titan

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

NBIP4 live mentions Neurocrine3 live mentions Clinical Trials Arena3 live mentions Phase I2 live mentions Study2 live mentions GLP2 live mentions GIP2 live mentions Glucagon Triple Agonist2 live mentions Investigational Obesity Drug2 live mentions Targets Three Receptors2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neurocrine Biosciences Begins.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.